OpGen offering to sell 3.75 million shares in initial public offering

Shares expected to price at between $8.00 and $10.00 each

By Susanna Moon

Chicago, April 14 – OpGen, Inc. will sell 3.75 million shares in its initial public offering of common stock with a greenshoe, according to an S-1/A filing with the Securities and Exchange Commission. The company had registered to sell up to $37.4 million shares March 3.

The company said it expects to price the shares at between $8.00 and $10.00 each.

Maxim Group LLC is the bookrunning manager. National Securities Corp. is the co-manager.

Proceeds will be used for sales and marketing, research and development and working capital purposes.

The Gaithersburg, Md., company uses molecular testing and bioinformatics to help combat multi-drug-resistant bacterial infections. It expects its shares to trade on the Nasdaq exchange under the symbol “OPGN.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.